Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
Deal Bird & Bird advises Nordic Unmanned Holding on strategic sale of AirRobot to Quantum Systems

Jun 03 2025

Read More
Deal Bird & Bird advises Signalbolaget Holding AB and founders on the divestment of all issued and outstanding shares

Jun 03 2025

Read More
Deal Bird & Bird advises Koskisen Corporation on strategic acquisition of Iisveden Metsä

Jun 02 2025

Read More
Deal Bird & Bird advises Emaldo on strategic acquisition of CheckWatt, cementing Nordic leadership in renewable energy

May 28 2025

Read More
Deal Bird & Bird advises Eulero Capital on the acquisition of DIEWE Wheels

May 27 2025

Read More
News Bird & Bird ATMD Celebrates Double Victory at the 2025 Asian Legal Business Southeast Asia Law Awards

May 26 2025

Read More